Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets

被引:200
|
作者
Potenza, Maria Assunta [1 ]
Gagliardi, Sara [1 ]
Nacci, Carmela [1 ]
Carratu, Maria Rosaria [1 ]
Montagnani, Monica [1 ]
机构
[1] Univ Bari, Dept Pharmacol & Human Physiol, Sch Med, I-70124 Bari, Italy
关键词
Endothelial dysfunction; diabetes; nitric oxide; reactive oxygen species; therapeutic strategies; NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; GLYCATION END-PRODUCTS; FACTOR-KAPPA-B; INTRAVITREAL BEVACIZUMAB AVASTIN; PROLIFERATOR-ACTIVATED RECEPTORS; IMPROVES INSULIN SENSITIVITY; CONVERTING ENZYME-INHIBITORS; NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS;
D O I
10.2174/092986709787002853
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Micro- and macrovascular complications are major causes of disability and death in patients with diabetes mellitus. Functional impairment of endothelial activity precedes the development of morphological alterations during the progression of diabetes. This endothelial dysfunction results from reduced bioavailability of the vasodilator nitric oxide (NO), mainly due to accelerated NO degradation by reactive oxygen species (ROS). Although hyperglycemia, insulin resistance, hyperinsulinemia and dyslipidemia independently contribute to endothelial dysfunction via several distinct mechanisms, increased oxidative stress seems to be the first alteration triggering several others. Mechanisms proposed to explain glucose- and lipid-induced vascular alterations in diabetes include accelerated formation of advanced glycation end-products (AGEs), protein kinase C activation, inflammatory signaling and oxidative stress. Insulin resistance with impaired PI 3-kinase effects decreases insulin mediated production of NO and reduces vasodilation, capillary recruitment and antioxidant properties of endothelium. Compensatory hyperinsulinemia enhances activation of intact MAP-kinase pathways and contributes to pro-atherogenic events by increasing secretion of endothelin-1 (ET-1), stimulating expression of adhesion molecules such as VCAM-1 and E-selectin, and inducing production of ROS. Conventional therapies to reduce hyperglycemia, dyslipidemia and insulin resistance may effectively improve endothelial function and delay the onset of vascular complications. Novel therapeutic approaches designed to inhibit AGEs formation, reduce PKC activation, decrease inflammatory signals and restore the ox/redox balance of endothelium may be predicted to ameliorate vascular function in diabetic state. This review summarizes the current knowledge on the most important mechanisms involved in endothelial dysfunction during diabetes. In addition, novel therapeutic strategies that may result from recently identified targets are also described.
引用
收藏
页码:94 / 112
页数:19
相关论文
共 50 条
  • [1] Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets
    Anna Janaszak-Jasiecka
    Agata Płoska
    Joanna M. Wierońska
    Lawrence W. Dobrucki
    Leszek Kalinowski
    [J]. Cellular & Molecular Biology Letters, 28
  • [2] Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets
    Janaszak-Jasiecka, Anna
    Ploska, Agata
    Wieronska, Joanna M. M.
    Dobrucki, Lawrence W. W.
    Kalinowski, Leszek
    [J]. CELLULAR & MOLECULAR BIOLOGY LETTERS, 2023, 28 (01)
  • [3] Therapeutic targets for endothelial dysfunction in vascular diseases
    Diem Thi Ngoc Huynh
    Heo, Kyung-Sun
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2019, 42 (10) : 848 - 861
  • [4] Therapeutic targets for endothelial dysfunction in vascular diseases
    Diem Thi Ngoc Huynh
    Kyung-Sun Heo
    [J]. Archives of Pharmacal Research, 2019, 42 : 848 - 861
  • [5] Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets
    Fodor, Adriana
    Tiperciuc, Brandusa
    Login, Cezar
    Orasan, Olga H.
    Lazar, Andrada L.
    Buchman, Cristina
    Hanghicel, Patricia
    Sitar-Taut, Adela
    Suharoschi, Ramona
    Vulturar, Romana
    Cozma, Angela
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
  • [6] Endothelial dysfunction in diabetes: multiple targets for treatment
    Hong Ding
    Chris R. Triggle
    [J]. Pflügers Archiv - European Journal of Physiology, 2010, 459 : 977 - 994
  • [7] Endothelial dysfunction in diabetes: multiple targets for treatment
    Ding, Hong
    Triggle, Chris R.
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2010, 459 (06): : 977 - 994
  • [8] NOVEL MECHANISMS OF ENDOTHELIAL DYSFUNCTION AND ATHEROTHROMBOSIS IN SLE: CAN WE IDENTIFY EFFECTIVE THERAPEUTIC TARGETS?
    Kaplan, M.
    [J]. RHEUMATOLOGY, 2012, 51 : I5 - I5
  • [9] Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets
    Scioli, Maria Giovanna
    Storti, Gabriele
    D'Amico, Federico
    Rodriguez Guzman, Roger
    Centofanti, Federica
    Doldo, Elena
    Cespedes Miranda, Ela Maria
    Orlandi, Augusto
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 39
  • [10] Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction
    Xu, Jian
    Zou, Ming-Hui
    [J]. CIRCULATION, 2009, 120 (13) : 1266 - 1286